PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)
Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla, Krushna Chandra Hembram, Chanakya Nath Kundu
Topics & Concepts
AngiogenesisVeliparibCurcuminCancer researchPharmacologyProtein kinase BPI3K/AKT/mTOR pathwayCancerPARP inhibitorNectinCancer cellMedicineChemistryApoptosisPoly ADP ribose polymeraseCellBiochemistryInternal medicineCell adhesionPolymeraseGeneRetinoids in leukemia and cellular processesCell death mechanisms and regulationCurcumin's Biomedical Applications